Loading clinical trials...
Loading clinical trials...
To determine whether the combination of MM-111 plus paclitaxel and trastuzumab is more effective than paclitaxel and trastuzumab alone
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Merrimack Pharmaceuticals
NCT05780684 · Colorectal Cancer, Esophagus Cancer, and more
NCT07617246 · Esophagus Cancer, Lung Cancer
NCT06921928 · Gastric Cancer, Gastroesophageal Junction Cancer, and more
NCT02530983 · Esophageal Neoplasms, Cancer of Esophagus, and more
NCT06346392 · Gastric Cancer, Gastroesophageal Junction Cancer
Birmingham, Alabama
Los Angeles, California
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions